Skip to main content
Contact Us
Subscribe
E-Edition
70°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about CMNDF
Recent news which mentions CMNDF
This Psychedelics Company Begins Trading On NASDAQ With $7.5M Offering Then Reverse Stock Split
November 15, 2022
Tickers
CMND
CMNDF
Tags
News
Benzinga
Psychedelics
From
Benzinga
Psychedelics Biotechs Clearmind And Mydecine Share Consolidation And Subscription Agreements
September 26, 2022
Tickers
CMNDF
MYCOF
Tags
Psychedelics
Contracts
Stock Split
From
Benzinga
SciSparc And Clearmind Partnership Yields 3rd Patent Application For The Treating Of Obesity And Metabolic Syndromes
September 22, 2022
Tickers
CMNDF
SPRC
Tags
Market News
Cannabis
Penny Stocks
From
Benzinga
Additional Positive Results Revealed In Cocaine Addiction Treatment Through SciSparc-Clearmind Collaboration
August 25, 2022
Tickers
CMNDF
SPRC
Tags
Penny Stocks
Partner Content
Market News
From
Benzinga
SciSparc Ltd. Announces Additional Positive Results for the Cocaine Addiction Treatment of its Psychedelic-based Pharma Collaboration with Clearmind Medicine Inc.
August 25, 2022
Tickers
CMNDF
SPRC
Tags
Benzinga
SciSparc
CMNDF
From
Benzinga
Psychedelic-Based Cocaine Addiction Treatment Study Showing Positive Results. This Is What We Know
August 24, 2022
Tickers
CMNDF
SPRC
Tags
Psychedelics
Markets
psychedelic compound MEAI
From
Benzinga
Psyched: Christie's Launches NFT Collection Supporting Psychedelic Science, Origin's Listing On CSE Gives Retail Investors Access To Private Companies
June 08, 2022
Tickers
CMNDF
CYBN
EHVVF
NMLSF
Tags
RVVTF
CMNDF
Beeple
From
Benzinga
The Bad And The Ugly? The State Of Excessive Alcohol Consumption In The U.S.
June 08, 2022
Tickers
CMNDF
SOBR
Tags
Market News
Partner Content
SOBR Safe
From
Benzinga
SciSparc Ltd. Announces Initial Positive Results For The Cocaine Addiction Treatment Of Clearmind Medicine Inc.
June 07, 2022
Tickers
CMNDF
SPRC
Tags
Biotech
Partner Content
Market News
From
Benzinga
SciSparc & Clearmind Medicine Team Up On Patent For Psychedelic Combination To Treat Cocaine Addiction
June 02, 2022
Tickers
CMNDF
SPRC
Tags
Psychedelics
Cannabis
Market News
From
Benzinga
SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields Another Patent Application for their Proprietary Psychedelic Combination to Treat Cocaine Addiction
June 02, 2022
Tickers
CMNDF
SPRC
Tags
Market News
Partner Content
Biotech
From
Benzinga
New Psychedelic-Based Alcohol Substitute Approved In India, Produced By Clearmind Medicine
June 01, 2022
Tickers
ASIA
CMNDF
Tags
CMNDF
Designs and Trademarks
Asia
From
Benzinga
High Hopes For Alcohol Use Disorder Treatment: Clearmind's Successful Pre-IND Meeting With The FDA
May 26, 2022
Tickers
CMNDF
Tags
Cannabis
Market News
alcohol use disorder
From
Benzinga
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company
May 24, 2022
Tickers
AWKNF
CMNDF
CMPS
IWINF
Tags
AWKNF
Prof/ Celia Morgan
Cannabis
From
Benzinga
Psychedelic Treatment For Alcoholism? Clearmind Medicine And SciSparc Collaboration Yields Positive Results
May 24, 2022
Tickers
CMNDF
SPRC
Tags
Market News
Psychedelics
Cannabis
From
Benzinga
Clearmind: Positive Preclinical Evidence For Flagship Psychedelic Molecule, Looks To Human Trials Before Year End
May 19, 2022
Tickers
CMNDF
Tags
Biotech
Market News
Cannabis
From
Benzinga
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies
May 17, 2022
Tickers
ATAI
CMNDF
CMPS
DELCF
Tags
ATAI
Markets
NUMIF
From
Benzinga
Has Clearmind Developed A Psychedelics-Based Drug That Can Treat Alcoholism? The FDA Is Interested
May 13, 2022
Tickers
CMNDF
SPRC
Tags
CMNDF
SPRC
Penny Stocks
From
Benzinga
SciSparc And Clearmind Reveal Potential To Reduce Alcohol Consumption With Psychedelic Treatment In New Patent Application
May 11, 2022
Tickers
CMNDF
SPRC
Tags
Markets
Penny Stocks
Market News
From
Benzinga
SciSparc And Clearmind Medicine Inc. Collaboration Yields New Patent Application For Psychedelic Combination Treatment For Binge Behaviors
May 10, 2022
Tickers
CMNDF
SPRC
Tags
Penny Stocks
Markets
Market News
From
Benzinga
Alcoholism & Psychedelics: Clearmind Trials Reveal Certain Psychedelics Help Reduce Alcohol Consumption In Mice
March 17, 2022
Tickers
CMNDF
SPRC
Tags
News
SPRC
CMNDF
From
Benzinga
Clearmind Medicine, SciSparc Launch A Psychedelic Pharma Collaboration
March 08, 2022
Tickers
CMNDF
SPRC
Tags
Markets
Penny Stocks
Cannabis
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.